Secondary hyperparathyroidism and osteopenia in women following gastric exclusion surgery for obesity

Osteoporos Int. 1991 Jun;1(3):177-81. doi: 10.1007/BF01625450.


Gastric exclusion has been introduced as a surgical treatment for morbid obesity. We describe two women who had undergone gastric bypass for obesity with metabolic bone disease and secondary hyperparathyroidism. In one patient transiliac bone biopsy after double tetracycline labelling demonstrated histologic evidence of hyperparathyroidism with osteitis fibrosa cystica. Six additional women who had undergone gastric exclusion were evaluated. Serum phosphorus, calcium, and creatinine were normal in all but one patient who had hypocalcemia. Serum immunoreactive parathyroid hormone was elevated in seven of eight patients and urinary calcium was less than or equal to 2 mmol/d (80 mg/24 h) in 6 patients. Lumbar spine bone mineral density was 86 +/- 7 (mean +/- SE) per cent of predicted and femoral neck bone mineral density was 89 +/- 6 per cent of predicted. Women who have had gastric exclusion for obesity may develop secondary hyperparathyroidism which could result in loss of bone mass.

Publication types

  • Case Reports

MeSH terms

  • Bone Diseases, Metabolic / etiology*
  • Female
  • Gastric Bypass / adverse effects*
  • Gastroplasty / adverse effects
  • Humans
  • Hyperparathyroidism, Secondary / etiology*
  • Middle Aged